J M Ray|W G Stetler-Stevenson - JoVE Visualize

Showing results (91-100 of 175) with videos related to

Pageof 18

Sort By:

Cancer Research|October 15, 1992

Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenaseH P Emonard, A G Remacle, A C Noël, et al.

Biochemistry|November 29, 1994

Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9J Ochieng, R Fridman, P Nangia-Makker, et al.

International Journal of Cancer|November 15, 1995

Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase AH Kawamata, S Kameyama, K Kawai, et al.

AIDS (London, England)|September 1, 1994

Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2A Albini, G Fontanini, L Masiello, et al.

International Journal of Cancer|February 15, 1994

Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodiesM Höyhtyä, R Fridman, D Komarek, et al.

The American Journal of Pathology|March 1, 1991

Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigensW F Grigioni, S Garbisa, A D'Errico, et al.

International Journal of Cancer|October 21, 1992

Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cellsF A van den Brûle, J Engel, W G Stetler-Stevenson, et al.

FEBS Letters|May 1, 1995

Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complexM R Emmert-Buck, H P Emonard, M L Corcoran, et al.

Cancer Research|January 1, 1991

Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinomaA T Levy, V Cioce, M E Sobel, et al.

Kidney International|July 2, 1998

Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitorK Ota, W G Stetler-Stevenson, Q Yang, et al.

Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:

Pageof 18

Cancer Research|October 15, 1992

Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenaseH P Emonard, A G Remacle, A C Noël, et al.

Biochemistry|November 29, 1994

Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9J Ochieng, R Fridman, P Nangia-Makker, et al.

International Journal of Cancer|November 15, 1995

Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase AH Kawamata, S Kameyama, K Kawai, et al.

AIDS (London, England)|September 1, 1994

Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2A Albini, G Fontanini, L Masiello, et al.

International Journal of Cancer|February 15, 1994

Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodiesM Höyhtyä, R Fridman, D Komarek, et al.

The American Journal of Pathology|March 1, 1991

Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigensW F Grigioni, S Garbisa, A D'Errico, et al.

International Journal of Cancer|October 21, 1992

Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cellsF A van den Brûle, J Engel, W G Stetler-Stevenson, et al.

FEBS Letters|May 1, 1995

Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complexM R Emmert-Buck, H P Emonard, M L Corcoran, et al.

Cancer Research|January 1, 1991

Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinomaA T Levy, V Cioce, M E Sobel, et al.

Kidney International|July 2, 1998

Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitorK Ota, W G Stetler-Stevenson, Q Yang, et al.

Pageof 18